527 related articles for article (PubMed ID: 9756088)
21. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
Böselt I; Tramma D; Kalamitsou S; Niemeyer T; Nykänen P; Gräf KJ; Krude H; Marenzi KS; Di Candia S; Schöneberg T; Schulz A
Nephrol Dial Transplant; 2012 Apr; 27(4):1521-8. PubMed ID: 21917732
[TBL] [Abstract][Full Text] [Related]
22. Nephrogenic diabetes insipidus.
Knoers NV; Monnens LL
Semin Nephrol; 1999 Jul; 19(4):344-52. PubMed ID: 10435672
[TBL] [Abstract][Full Text] [Related]
23. Nephrogenic diabetes insipidus caused by mutation of Tyr205: a key residue of V2 vasopressin receptor function.
Sangkuhl K; Römpler H; Busch W; Karges B; Schöneberg T
Hum Mutat; 2005 May; 25(5):505. PubMed ID: 15841479
[TBL] [Abstract][Full Text] [Related]
24. [Congenital nephrogenic diabetes insipidus].
Thibonnier M
Rev Prat; 1994 May; 44(9):1169-72. PubMed ID: 7939338
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
[TBL] [Abstract][Full Text] [Related]
26. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
[TBL] [Abstract][Full Text] [Related]
27. Molecular biology of hereditary diabetes insipidus.
Fujiwara TM; Bichet DG
J Am Soc Nephrol; 2005 Oct; 16(10):2836-46. PubMed ID: 16093448
[TBL] [Abstract][Full Text] [Related]
28. Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus.
Oksche A; Dickson J; Schülein R; Seyberth HW; Müller M; Rascher W; Birnbaumer M; Rosenthal W
Biochem Biophys Res Commun; 1994 Nov; 205(1):552-7. PubMed ID: 7999078
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus.
van den Ouweland AM; Dreesen JC; Verdijk M; Knoers NV; Monnens LA; Rocchi M; van Oost BA
Nat Genet; 1992 Oct; 2(2):99-102. PubMed ID: 1303271
[TBL] [Abstract][Full Text] [Related]
30. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
Loonen AJ; Knoers NV; van Os CH; Deen PM
Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
[TBL] [Abstract][Full Text] [Related]
31. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
Ishikawa SE
Nihon Rinsho; 2002 Feb; 60(2):350-5. PubMed ID: 11857925
[TBL] [Abstract][Full Text] [Related]
32. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
van Os CH; Deen PM
Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
[TBL] [Abstract][Full Text] [Related]
33. A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.
de Mattia F; Savelkoul PJ; Bichet DG; Kamsteeg EJ; Konings IB; Marr N; Arthus MF; Lonergan M; van Os CH; van der Sluijs P; Robertson G; Deen PM
Hum Mol Genet; 2004 Dec; 13(24):3045-56. PubMed ID: 15509592
[TBL] [Abstract][Full Text] [Related]
34. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.
Boson WL; Della Manna T; Damiani D; Miranda DM; Gadelha MR; Liberman B; Correa H; Romano-Silva MA; Friedman E; Silva FF; Ribeiro PA; De Marco L
Genet Test; 2006; 10(3):157-62. PubMed ID: 17020465
[TBL] [Abstract][Full Text] [Related]
35. Nephrogenic diabetes insipidus due to a novel AVPR2 mutation.
Sakallioglu O; Tascilar ME; Kalman S; Cheong HI; Atay AA
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):187-9. PubMed ID: 19449677
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathogenesis of nephrogenic diabetes insipidus.
Nguyen MK; Nielsen S; Kurtz I
Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
[TBL] [Abstract][Full Text] [Related]
37. Molecular and cellular defects in nephrogenic diabetes insipidus.
Knoers NV; Deen PM
Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
[TBL] [Abstract][Full Text] [Related]
39. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
Savelkoul PJ; De Mattia F; Li Y; Kamsteeg EJ; Konings IB; van der Sluijs P; Deen PM
Hum Mutat; 2009 Oct; 30(10):E891-903. PubMed ID: 19585583
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
